Sertindole, a useful option in the treatment of schizophrenia, is not associated with an excess of overall mortality

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.22, Iss.12, 2006-12, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sertindole for the treatment of schizophrenia

By Azorin Jean-Michel Kaladjian Arthur Fakra Eric Adida Marc

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 3053-3064

Informa Healthcare

Access to resources Recommend Favorite

Sertindole: pharmacological and clinical profile and role in the treatment of schizophrenia

By Spina Edoardo Zoccali Rocco

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 5, 2008-05 ,pp. : 629-638

Informa Healthcare

Access to resources Recommend Favorite

Sertindole: A Review of its Use in Schizophrenia

By Murdoch David Keating Gillian M.

CNS Drugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 233-255

Adis International

Access to resources Recommend Favorite

Drug safety and efficacy evaluation of sertindole for schizophrenia

By Karamatskos Evangelos Lambert Martin Mulert Christoph Naber Dieter

Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. : 1047-1062

Informa Healthcare

Access to resources Recommend Favorite

Perospirone may be useful for the treatment of patients with schizophrenia accompanied by obesity or diabetes mellitus

Inpharma, Vol. 1, Iss. 1422, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite